Published in Oncotarget on March 31, 2017
Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making (2006) 11.83
The clinical usefulness of prostate specific antigen: update 1994. J Urol (1994) 3.64
Insignificant prostate cancer and active surveillance: from definition to clinical implications. Eur Urol (2009) 2.97
Is there evidence of a relationship between benign prostatic hyperplasia and prostate cancer? Findings of a literature review. Eur Urol (2008) 2.65
BPH: epidemiology and comorbidities. Am J Manag Care (2006) 2.01
The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation. Eur Urol (2011) 1.71
Optimization of prostate biopsy: the role of magnetic resonance imaging targeted biopsy in detection, localization and risk assessment. J Urol (2014) 1.55
The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. J Urol (1992) 1.29
Prostate cancer detection: relationship to prostate size. Urology (1999) 1.23
Accuracy of in-vivo assessment of prostatic volume by MRI and transrectal ultrasonography. J Comput Assist Tomogr (1992) 1.16
Prostate specific antigen density of the transition zone: a new effective parameter for prostate cancer prediction. J Urol (1997) 1.09
Prostate specific antigen best practice statement: 2009 update. J Urol (2013) 1.03
Serum PSA adjusted for volume of transition zone (PSAT) is more accurate than PSA adjusted for total gland volume (PSAD) in detecting adenocarcinoma of the prostate. Urology (1994) 0.93
Pitfalls in Interpreting mp-MRI of the Prostate: A Pictorial Review with Pathologic Correlation. Insights Imaging (2015) 0.91
Transrectal ultrasonography: why are estimates of prostate volume and dimension so inaccurate? Br J Urol (1996) 0.90
Clinical value of prostate segmentation and volume determination on MRI in benign prostatic hyperplasia. Diagn Interv Radiol (2014) 0.88
Age-related changes in prostate zonal volumes as measured by high-resolution magnetic resonance imaging (MRI): a cross-sectional study in over 500 patients. BJU Int (2012) 0.86
MRI-based prostate volume-adjusted prostate-specific antigen in the diagnosis of prostate cancer. J Magn Reson Imaging (2015) 0.86
Evaluation of prostate size: a comparison of ultrasound and magnetic resonance imaging. Urol Radiol (1987) 0.85
Prostate volume index and chronic inflammation of the prostate type IV with respect to the risk of prostate cancer. Urol Int (2014) 0.84
Prostate volumes derived from MRI and volume-adjusted serum prostate-specific antigen: correlation with Gleason score of prostate cancer. AJR Am J Roentgenol (2013) 0.84
Peripheral zone prostate-specific antigen density: an effective parameter for prostate cancer prediction in men receiving 5α-reductase inhibitors. Prostate Int (2013) 0.83
Rapid development of image analysis research tools: Bridging the gap between researcher and clinician with pyOsiriX. Comput Biol Med (2015) 0.83
Utility of the transition zone index for identification of prostate cancer in Chinese men with intermediate PSA levels. Int Urol Nephrol (2012) 0.83
The influence of prostate volume on cancer detection in the Chinese population. Asian J Androl (2014) 0.81
Prostate volumetric assessment by magnetic resonance imaging and transrectal ultrasound: impact of variation in calculated prostate-specific antigen density on patient eligibility for active surveillance program. J Comput Assist Tomogr (2013) 0.80
Transition zone prostate specific antigen density improves prostate cancer detection in Iranian men. Nephrourol Mon (2015) 0.77
The implications of prostate-specific antigen density to predict clinically significant prostate cancer in men ≤ 50 years. Am J Clin Exp Urol (2014) 0.77